Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-16-004147
Filing Date
2016-08-10
Accepted
2016-08-10 08:26:52
Documents
4
Period of Report
2016-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K oncolyticsform6k.htm 6-K 16473
2 NEWS RELEASE DATED AUGUST 10, 2016 ex991.htm EX-99.1 10954
3 GRAPHIC image_001.jpg GRAPHIC 26071
4 GRAPHIC image_002.jpg GRAPHIC 31299
  Complete submission text file 0001279569-16-004147.txt   107721
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 161820043
SIC: 2834 Pharmaceutical Preparations